Drug Therapy

Stephen B. Levine, MD
Clinical Professor of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH; Co-Director, Center for Marital and Sexual Health, and President, Center for Sexual Health Research, Beachwood, OH

Address: Stephen B. Levine, MD, Center for Marital and Sexual Health, 3 Commerce Park Square, Suite 350, Beachwood, OH 44122-5402

The author has indicated that he has received grant or research support from Pfizer corporation, is a consultant for Lilly-ICOS, and is on the speakers' bureaus of the Consortium for Improvement in Erectile Function and Pfizer.

The presentation on which this article is based was supported by an unrestricted educational grant from Lilly-ICOS LLC.

This article discusses therapies that are not approved by the US Food and Drug Administration.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Stephen B. Levine, MD
Clinical Professor of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH; Co-Director, Center for Marital and Sexual Health, and President, Center for Sexual Health Research, Beachwood, OH

Address: Stephen B. Levine, MD, Center for Marital and Sexual Health, 3 Commerce Park Square, Suite 350, Beachwood, OH 44122-5402

The author has indicated that he has received grant or research support from Pfizer corporation, is a consultant for Lilly-ICOS, and is on the speakers' bureaus of the Consortium for Improvement in Erectile Function and Pfizer.

The presentation on which this article is based was supported by an unrestricted educational grant from Lilly-ICOS LLC.

This article discusses therapies that are not approved by the US Food and Drug Administration.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Stephen B. Levine, MD
Clinical Professor of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH; Co-Director, Center for Marital and Sexual Health, and President, Center for Sexual Health Research, Beachwood, OH

Address: Stephen B. Levine, MD, Center for Marital and Sexual Health, 3 Commerce Park Square, Suite 350, Beachwood, OH 44122-5402

The author has indicated that he has received grant or research support from Pfizer corporation, is a consultant for Lilly-ICOS, and is on the speakers' bureaus of the Consortium for Improvement in Erectile Function and Pfizer.

The presentation on which this article is based was supported by an unrestricted educational grant from Lilly-ICOS LLC.

This article discusses therapies that are not approved by the US Food and Drug Administration.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Eric A. Klein, MD
Head, Section of Urologic Oncology, Urological Institute, The Cleveland Clinic; National Study Coordinator, Selenium and Vitamin E Cancer Prevention Trial

Address: Eric A. Klein, MD, Department of Urology, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Eric A. Klein, MD
Head, Section of Urologic Oncology, Urological Institute, The Cleveland Clinic; National Study Coordinator, Selenium and Vitamin E Cancer Prevention Trial

Address: Eric A. Klein, MD, Department of Urology, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Eric A. Klein, MD
Head, Section of Urologic Oncology, Urological Institute, The Cleveland Clinic; National Study Coordinator, Selenium and Vitamin E Cancer Prevention Trial

Address: Eric A. Klein, MD, Department of Urology, A100, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Mitchell Lee Gaynor, MD
Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York

Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: [email protected]

The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.

Mitchell Lee Gaynor, MD
Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York

Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: [email protected]

The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.

Mitchell Lee Gaynor, MD
Assistant Clinical Professor of Medicine, The New York Hospital, Cornell Medical Center; Medical Director and Director, Medical Oncology, Weill-Cornell Center for Complementary and Integrative Medicine, New York

Address: Mitchell Lee Gaynor, MD, The New York Hospital, Cornell Medical Center, 428 East 72nd Street, Suite 100, New York, NY 10021; e-mail: [email protected]

The author states that preparation of this article was supported by an unrestricted educational grant from Novogen, Inc.

Randall C. Starling, MD, MPH
Section of Heart Failure and Cardiac Transplant Medicine, Kaufman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Randall C. Starling, MD, MPH, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

The author has indicated that he has received grant or research support from Acorn Cardiovascular corporation, and is a consultant for Novartis.

This paper discusses therapies that are experimental or not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

Randall C. Starling, MD, MPH
Section of Heart Failure and Cardiac Transplant Medicine, Kaufman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Randall C. Starling, MD, MPH, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

The author has indicated that he has received grant or research support from Acorn Cardiovascular corporation, and is a consultant for Novartis.

This paper discusses therapies that are experimental or not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

Randall C. Starling, MD, MPH
Section of Heart Failure and Cardiac Transplant Medicine, Kaufman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic

Address: Randall C. Starling, MD, MPH, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

The author has indicated that he has received grant or research support from Acorn Cardiovascular corporation, and is a consultant for Novartis.

This paper discusses therapies that are experimental or not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the authors but are not peer-reviewed.

Georgeanne Botek, DPM
Department of Orthopedic Surgery, The Cleveland Clinic

Address: Georgeanne Botek, DPM, Department of Orthopedic Surgery, A41, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Georgeanne Botek, DPM
Department of Orthopedic Surgery, The Cleveland Clinic

Address: Georgeanne Botek, DPM, Department of Orthopedic Surgery, A41, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Georgeanne Botek, DPM
Department of Orthopedic Surgery, The Cleveland Clinic

Address: Georgeanne Botek, DPM, Department of Orthopedic Surgery, A41, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: [email protected]

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: [email protected]

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: [email protected]

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]